The page cannot be displayed because you are using Internet Explorer version 8 or lower.

Please consider upgrading your browser here

Vi bruger cookies på denne hjemmeside. Ved at bruge hjemmesiden accepterer du vores brug af cookies. Accepter

 
 
 
 

May 12, 2016 - Novo Nordisk Foundation Cluster Lectures - Series 5

The Novo Nordisk Foundation Cluster Lectures are a series of open lectures for all researchers and other interested in and around the Copenhagen area. The fifth lecture on 12 May 2016 will feature 2 speakers on how to collaborate with hospitals and hospital researchers.

 

May 12, 2016 - Novo Nordisk Foundation Cluster Lectures - Series 5

CONCEPT

The Novo Nordisk Foundation Cluster Lectures are a series of open lectures for all researchers and other interested in and around the Copenhagen area. Every 4 weeks, on a Thursday evening, you are invited to Tuborg Havnevej for lectures on themes with a general interest for the Novo Nordisk Foundation Research Centers. Often there will be a cross-disciplinary focus. The fifth lecture on 12 May 2016 will give you an insight in how to collaborate with hospitals and hospital researchers.

PROGRAMME

15:45 Welcome and registration (coffee/tea, fruit, water available)

16:00 Keynotes by Peter Rossing on "Personlising treatment of diabetic kidney disease" and Marit E. Jørgensen "Lifestyle or genes in diabetes - what matter sin Greenland?" from Steno Diabetes Center

17:30  Networking with a drink and a bite

18:30 Thank you for a splendid end of day!

 

REGISTRATION

Registration is free of charge, but mandatory on our event's website on Eventbrite

 

SHORT BIO OF THE SPEAKERS

Professor Marit Eika Jørgensen, MD, PhD. is an endocrinologist and Head of Clinical Epidemiology at Steno Diabetes Centre and professor in Arctic Health at Southern Denmark University. Marit has conducted population studies of diabetes and cardiovascular disease among Greenland Inuit since 1998. The research activities include comparative studies of ethnic differences in obesity-associated risk and screening methods for diabetes in different ethnic groups. A further focus area is the demographic analysis of the burden of DM through linkage of the extensive collection of national registries. Both research lines are connected through use of the registries to follow participants of the cohorts. Marit is currently involved as PI or steering group member of studies focusing on DM, in close collaboration with national and international partners: Pre-D, ADDITION and ADDITION‐PRO, The Inuit Health in Transition study, and the LuCAMP study. Marit Eika Jørgensen is engaged in National Quality Assurance of diabetes care in Denmark and Greenland. She received the ‘burden of diabetes award’ under EASD in 2003 and is author of over 120 original research papers, reports and book chapters.

Professor Peter Rossing MD DMSc, is Head of Research and Chief Physician at Steno Diabetes Center. Peter Rossing graduated as a MD from the University of Copenhagen Medical School in 1991. After graduating he joined the Steno Diabetes Center as a research fellow 1991-96. After submitting his DMSc. thesis “Promotion, prediction and prevention of progression in diabetic nephropathy” defended in 1998, he entered his clinical training at the University of Copenhagen Hospitals, to obtain a specialist degree in internal medicine and endocrinology 2004. Since 2007 he has been a chief physician and manager of the Steno Diabetes Center research team dedicated to the research of micro-and macrovascular complications of diabetes, and from 2010-14 and 2016- Head of Research at SDC. Since 2012 Professor in diabetic angiopathy at University of Copenhagen and at Aarhus University. Peter Rossing has in epidemiological studies investigated key features of the pathophysiology of the diabetic kidney at different stages. He has identified several markers for development of diabetic nephropathy, making it possible to predict the individual risk He demonstrated that a reduction in urinary albumin excretion after onset of antihypertensive therapy in diabetic nephropathy was the best predictor of a successful treatment outcome. He has been involved in several intervention studies in patients with overt diabetic nephropathy aiming at improving the prognosis. He has co-authored >300 papers, and his h-index is 55. Coordinator of the EU FP7 project PRIORITY and the NNF Challenge grant PROTON. Received the Minkowski prize from the EASD in 2005, Ruth Østerby award in 2013 and Golgi award 2016. Past president of the Danish Endocrine Society, current president of the European Diabetic Nephropathy Study group and chairman of the Danish National Diabetes Registry.

 

SAVE THE DATE

The next Cluster Lecture will take place on 16 June 2016. We look forward to meeting you there too! Do you have a good idea for a theme or inspiring speakers? Contact us at sfeb@novo.dk

 

FAQs

I would like to know more about upcoming Novo Nordisk Foundation Cluster Lectures - where can I find information?

You are very welcome to join the 'Novo Nordisk Foundation Research Centers' Linkedin group. There you will find information about upcoming lectures, and much more. Also, you may want to sign up for the weekly announcement with events and deadlines, sent out by the group manager. 

What are my transport/parking options getting to the event?

You can park for free in front or at the side of Tuborg Havnevej 19. If that is full, there is 3 hours free parking in the parking to the Waterfront shopping mall at the end of the road.

Public transport by train to Hellerup station, and/or bus (1A, 21, 166), nearest by bus stop is Tuborg Boulevard.

How do I cancel my participation?

Please help us respecting our speakers, as well keeping track of the numbers and optimize lecture and catering to the audience by cancelling as soon as you know that you exceptionally will not be able to make it. You can either cancel through Eventbrite or send an email to Sophie Labrosse (sfeb@novo.dk).

Where can I contact the organizer with any questions?

Contact Sophie Labrosse at sfeb@novo.dk